Zobrazeno 1 - 10
of 84
pro vyhledávání: '"S F, Sokolov"'
Autor:
N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. V. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 5, Pp 668-673 (2021)
Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon for conversion of atrial fibrillation (AFib) and flutter (AFl) in post-registration trial and to compare data of primary center (National medical research cent
Externí odkaz:
https://doaj.org/article/fda3bc3bcec0409e89ef6af250af93a3
Autor:
N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. S. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 2, Pp 193-199 (2021)
Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon for conversion of atrial fibrillation (AFib) and flutter (AFl) in post-registration trial and to compare data of primary center (National medical research cent
Externí odkaz:
https://doaj.org/article/0f377f87549f4a628c7889891fa7039f
Publikováno v:
Терапевтический архив, Vol 91, Iss 4, Pp 83-89 (2019)
Aim. To evaluate standard 12-lead ECG indices for the differential diagnosis of wide QRS tachycardias with right bundle branch block (RBBB) pattern. Materials and methods. Study analyses the 244 ECG indices in 111 patients (79 males and 32 females, a
Externí odkaz:
https://doaj.org/article/dea4f93ef3b44589a8aff943c3e83f2f
Autor:
N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 14, Iss 6, Pp 826-830 (2019)
Aim. To compare safety of new class III antiarrhythmic drug Refralon with direct current cardioversion (DCC) in patients with persistent atrial fibrillation (AF). Material and methods. 60 patients with persistent AF were randomized to groups of DCC (
Externí odkaz:
https://doaj.org/article/f47249aaf92d44f9aa129d5064c2d1e0
Autor:
N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 14, Iss 5, Pp 664-669 (2018)
Aim. We aimed to compare effectiveness of new class III antiarrhythmic drug Refralon with direct current cardioversion (DCC) in patients with persistent atrial fibrillation (AF).Material and methods. 60 patients with persistent AF were randomized to
Externí odkaz:
https://doaj.org/article/0ac2b7081f3446bc854ffbc0cfffd425
Publikováno v:
Kardiologiia. 63:68-76
This review summarizes the available information on the epidemiology and prognosis of patients with left bundle branch block (LBBB), morphological alterations of the myocardium both resulting in and ensuing LBBB, cardiac biomechanics in LBBB, and pos
Autor:
A. Zh. Gasparyan, E. V. Guseva, G. S. Tarasovsky, S. Yu. Kashtanova, M. D. Utsumueva, T. V. Sharf, N. A. Mironova, S. F. Sokolov, V. P. Masenko, A. A. Skvortsov, N. B. Shlevkov
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 12 (2020)
Aim. To study the changes in N-terminal pro-brain natriuretic peptide (NT-proBNP) and growth stimulation gene-2 (sST2) to predict isolated episodes of ventricular tachyarrhythmias (VTA) and electrical storm (ES) in patients with systolic heart failur
Externí odkaz:
https://doaj.org/article/b7ac96f7e7234c939433702ffb7e8890
Autor:
P. S. Novikov, A. V. Pevzner, A. V. Shlevkov, E. V. Maykov, N. Yu. Mironov, S. F. Sokolov, S. P. Golitsyn
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 7, Pp 125-131 (2017)
Aim. Comparison study of the parameters of intracardiac electrophysiological study (EPS) in patients with the typical atrial flutter (TAF) and atrial fibrillation (AF), of the courses as isolated types of arrhythmia.Material and methods. Totally, 82
Externí odkaz:
https://doaj.org/article/76783327def84a8db5baf5a0b21db32d
Autor:
A. V. Pevzner, E. Sh. Bayrambekov, A. Yu. Litvin, E. M. Elfimova, V. V. Ermishkin, S. F. Sokolov, S. P. Golitsyn
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 7, Pp 111-116 (2017)
Aim. Evaluation of CPAP treatment (continuous positive upper airway pressure) in obstructive sleep apnea patients (OSA) and atrial fibrillation (AF) in comparison with antiarrhythmic medication therapy.Material and methods. Totally, 36 patients inclu
Externí odkaz:
https://doaj.org/article/c8b1a5f3eeb848248246939f7f1afb38
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 3, Iss 5, Pp 45-53 (2015)
Aim. To evaluate effects of angiotensin converting enzyme inhibitor spirapril on efficacy of preventive antiarrhythmic therapy in patients with paroxysmal atrial fibrillation (AF).Material and methods. 40 patients with paroxysmal AF were involved in
Externí odkaz:
https://doaj.org/article/143f305257844d73a518e36ed542289b